<p>Four biopharma CEOs discuss with Rob Wright, chief editor of Life Science Leader, how they are leading their organizations and conducting drug development during the COVID-19 pandemic.</p>

Four biopharma CEOs discuss with Rob Wright, chief editor of Life Science Leader, how they are leading their organizations and conducting drug development during the COVID-19 pandemic.

Special Edition #3: Leading Through Adversity: A CEO Roundtable On Drug Development During A Pandemic

Life Science Connect Editorial Director, Dan Schell, works with a talented and passionate group of editors. Each week, he sits down with them to discuss their pressing coverage areas, latest travels, and interesting interviews from within the life sciences landscape. His rotating cast of contributors includes Life Science Connect editors Rob Wright, Ed Miseta, Louis Garguilo, Anna Rose Welch, Erin Harris, and Matt Pillar.

Share Special Edition #3: Leading Through Adversity: A CEO Roundtable On Drug Development During A Pandemic

Sign up to save your podcasts

Special Edition #3: Leading Through Adversity: A CEO Roundtable On Drug Development During A Pandemic

Special Edition #3: Leading Through Adversity: A CEO Roundtable On Drug Development During A Pandemic